March 10, 2026 Rapid Novor Inc., a Canadian biotechnology leader, announced today that its diagnostic laboratory has received a provisional license from the Ontario Ministry of Health (MOH) for its EasyM® assay, enabling the company to begin testing patients in Canada. This milestone represents the first time highly sensitive measurable residual disease (MRD) monitoring [...]

We are proud to be part of a newly published peer-reviewed study in Nature Communications. By combining PASEF-enabled mass spectrometry with de novo protein sequencing, the team greatly improved sensitivity and detection in complex microbiomes. The approach introduces the concept of a "druggable metaproteome", offering a new framework to advance microbiome research and develop [...]

A Canadian Multiple Myeloma (MM) clinical trial sponsored by Rapid Novor, has enrolled its first patient. This is the first Canadian prospective clinical study aiming to evaluate the EasyM™ assay (mass spectrometry measurement of a myeloma biomarker) for disease response in newly diagnosed MM patients (NDMM) receiving standard of care treatment. A clinical [...]

Rapid Novor Inc., the world’s leader in mass spectrometry (MS)-based antibody protein sequencing, announced today that its REpAb® antibody discovery platform was used to successfully sequence a complex mixture of functional antibodies directly from the serum of a human patient after receiving a COVID-19 vaccine. “This demonstrates a significant breakthrough in antibody discovery technology [...]

Bruker Launches de novo Sequencing for Immunopeptidomics, Library-Free dia-PASEF, Mass Dynamics Knowledge Visualization At the 19th US HUPO, Bruker Corporation (Nasdaq: BRKR) announced important bioinformatics launches for 4D-Proteomics on the timsTOF platform: A novel de novo sequencing algorithm was developed in collaboration with Rapid Novor Inc., using over 1.7 million PASEF data-points to improve accuracy [...]

Rapid Novor First to Decode Polyclonal Antibodies Using Only Proteomics Rapid Novor Inc., the world's leader in antibody protein sequencing using mass spectrometry, announced today that it has reached a major milestone in the life sciences industry by being the first to successfully sequence polyclonal antibodies directly from proteins without DNA sequencing data. The team [...]

How Rapid Novor is Responding to COVID-19 Our Commitment to Our Clients and Team Members Rapid Novor, Inc. recognizes the importance of maintaining the health and well-being of both our clients and dedicated team members. This is why we have incorporated additional health and safety protocols. These new protocols include mobilizing our team, [...]

Written by María Gerpe, Scientific Writer Meet Anthony: he likes having a quality meal. Balanced. With healthy fats like avocado. Anthony wakes up every morning to the smell of coffee and a strong sense of carpe diem. He doesn’t just employ the art of positive visualization, popularized by The Sopranos. His dogma, if a TV [...]